NASDAQ:AXSM

Axsome Therapeutics Stock News

etoro logo Buy AXSM
*Your capital is at risk
$212.17
+1.13 (+0.535%)
At Close: Aug 04, 2026
Each of these stocks is ready for a rebound.
Immunocore, Axsome Therapeutics, and Takeda are significantly outperforming the market this year.
Here's why these Fool.com contributors are bullish on Adaptimmune Therapeutics, G1 Therapeutics, and Axsome Therapeutics.

Axsome: One Step At A Time

04:08pm, Friday, 01'st Jul 2022
AXS-05 labeling discussions with the FDA imply imminent approval. Next 12-18 months will see Axsome transform into a significant commercial neuroscience biotech.
Axsome's (AXSM) extension of the review period for AXS-05 NDA and CRL for AXS-07 NDA hurt prospects. However, recent positive updates on AXS-05 are driving positive sentiments.

2 Biotechs That Recently Soared -- Are They Buys?

10:23am, Thursday, 30'th Jun 2022
Let's consider the risk-reward profile of these companies before jumping on the bandwagon.
Axsome (AXSM) receives proposed labeling from the FDA for its under-review depression drug candidate, AXS-05, implying a potential approval soon. Shares surge more than 50%.
While individuals are fearing another pandemic, could health care stocks be a great addition to your watchlist?
The Food and Drug Administration could be nearing a decision on Axsome Therapeutics' depression treatment, and AXSM stock rocketed Monday. The post Axsome Therapeutics Just Took Its Key Moving Average

Axsome Therapeutics Stock Surges on FDA Update

10:49am, Monday, 27'th Jun 2022
Axsome Therapeutics Inc  (NASDAQ:AXSM) is surging today, after the company said it has received proposed labeling from the Food and Drug Administration (FDA) for AXS-05, its drug candidate to treat
Axsome Therapeutics (AXSM) stock is rising higher on Monday following an update from the FDA about product labeling for one of its drugs. The post Axsome Therapeutics (AXSM) Stock Soars on FDA Labelin
A tiny biotech company got great news to start off the week.

Why Axsome Therapeutics Stock Is On Fire Today

09:16am, Monday, 27'th Jun 2022
The biotech appears to be close to securing final approval for its major depressive disorder drug.

Why Axsome Therapeutics Stock Is Soaring Today

08:52am, Monday, 27'th Jun 2022
Axsome Therapeutics Inc (NASDAQ: AXSM) shares are trading higher Monday after the company received proposed labeling from the U.S. Food and Drug Administration for its treatment of major depressiv

3 Stocks That Could Double by 2025

05:58am, Sunday, 19'th Jun 2022
These companies have realistic prospects of achieving tremendous growth.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE